Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004581705 | SCV005065809 | pathogenic | Developmental and epileptic encephalopathy, 9 | 2023-05-01 | criteria provided, single submitter | clinical testing | This variant disrupts a region of the PCDH19 protein in which other variant(s) (p.Pro567Leu) have been determined to be pathogenic (PMID: 21053371, 30530412). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with PCDH19-related conditions. This variant results in the deletion of part of exon 1 (c.-36660_1723del) of the PCDH19 gene. |